(Q40468650)

20 September 2017

Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer. (English)

1 reference

20 September 2017

1 reference

3

1 reference

20 September 2017

Annemieke de Jong

1

0 references

Cornelis J. M. Melief

9

object named as

Cornelis J M Melief

1 reference

20 September 2017

Sjoerd H van der Burg

8

object named as

Sjoerd H van der Burg

1 reference

20 September 2017

5

Kees L M C Franken

1 reference

20 September 2017

Jeanette M van der Hulst

2

1 reference

20 September 2017

Jan Wouter Drijfhout

4

1 reference

20 September 2017

Pieter Vermeij

6

1 reference

20 September 2017

Rienk Offringa

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

International Journal of Cancer

20 September 2017

1 reference

20 September 2017

114

1 reference

20 September 2017

2

1 reference

20 September 2017

274-282

1 reference

Papillomavirus infections--a major cause of human cancers

20 September 2017

1 reference

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.

21 January 2018

1 reference

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

21 January 2018

1 reference

Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen

21 January 2018

1 reference

Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.20721

1 reference

20 September 2017

1 reference